1. Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial. (4th November 2015) Authors: Haas, Naomi B; Stein, Mark N; Tutrone, Ronald; Perini, Rodolfo; Denker, Andrew; Mauro, David; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial. Issue 2 (December 2015) Authors: Haas, Naomi; Stein, Mark; Tutrone, Ronald; Perini, Rodolfo; Denker, Andrew; Mauro, David; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 2(2016) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 2(2016) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial. (March 2021) Authors: Atkins, Michael B.; Plimack, Elizabeth R.; Puzanov, Igor; Fishman, Mayer N.; McDermott, David F.; Cho, Daniel C.; Vaishampayan, Ulka; George, Saby; Tarazi, Jamal C.; Duggan, William; Perini, Rodolfo; Thakur, Mahgull; Fernandez, Kathrine C.; Choueiri, Toni K. Journal: European journal of cancer Issue: Volume 145(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma. (3rd October 2022) Authors: Donskov, Frede; Pinto, Cathy Anne; Predoiu, Raluca; Fox, Claire; Georgsen, Jeanette Baehr; Skaarup, Katrine; Burcu, Mehmet; Perini, Rodolfo; Steiniche, Torben Journal: Acta oncologica Issue: Volume 61:Number 10(2022) Page Start: 1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective. Issue 10 (October 2013) Authors: Patel, Vatsal; Buckstein, Michael; Perini, Rodolfo; Hill-Kayser, Christine; Svoboda, Jakub; Plastaras, John P. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 10(2013:Oct.) Page Start: 2168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗